Xamoterol - CISMeF

Preferred Label : Xamoterol;

NCIt synonyms : ( -)-N-(2-((2-Hydroxy-3-(p-hydroxyphenoxy)propyl)amino)ethyl)-4-morpholinecarboxamide; 4-Morpholinecarboxamide, N-(2-((2-hydroxy-3-(4-hydroxyphenoxy)propyl)amino)ethyl)-, ( -)-;

UNII : 7HE0JQL703;

InChIKey : DXPOSRCHIDYWHW-UHFFFAOYSA-N;

CAS number : 81801-12-9;

Chemical formula : C16H25N3O5;

Details

Origin ID

C81344;

UMLS CUI

C0078595;

Currated CISMeF NLP mapping
- Xamoterol [ICD-11 Extension code]
- Xamoterol (substance) [SNOMED CT concept]
- xamoterol [MeSH Descriptor]
- xamoterol [MeSH concept]
See also inter- (CISMeF)
- Product containing xamoterol (medicinal product) [SNOMED CT concept]
- Xamoterol adverse reaction (disorder) [SNOMED CT concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Product containing xamoterol (medicinal product) [SNOMED CT concept]
- Xamoterol [ICD-11 Extension code]
- Xamoterol (substance) [SNOMED CT concept]
- xamoterol [ATC Code]
- xamoterol [MeSH concept]
- xamoterol [MeSH Descriptor]
Validated automatic mappings to BTNT
- xamoterol [ATC Code]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients